Medicare will cover the cost of a pilot of weight-loss drug coverage, after health insurers refuse to take part.

A new targeted treatment for a rare and aggressive bile duct cancer has been approved by NICE, offering patients the chance of longer survival and

Roche’s multiple sclerosis pill more than doubled patients’ relapse-free interval compared with Sanofi’s marketed MS pill Aubagio, according to data presented late on Tuesday. The

The Centers for Medicare and Medicaid Services has delayed a key pilot program focused on Medicare coverage for obesity medications, after insurance plans indicated they

China is “eating our lunch” on new drug approvals and clinical trial starts, HHS Secretary Robert F. Kennedy Jr. told Congress Tuesday, while praising the